Announcements Trials
Browse Landscape

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Gynecologic 3Lymphoid 2Head & Neck 2Genitourinary 2Thoracic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Endocrine 1CNS 1Breast 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 98daratumumab 57Lenalidomide 53Bortezomib 38pomalidomide 37Cyclophosphamide 37carfilzomib 25Calcium Dobesilate 25fludarabine 22talquetamab 19iberdomide 18isatuximab 17Specimen Handling 17Magnetic Resonance Spectroscopy 17Biopsy 15selinexor 13dexamethasone acetate 12belantamab mafodotin 12Melphalan 12dexamethasone 21-phosphate 11auricularum 10venetoclax 8fludarabine phosphate 7elotuzumab 7X-Rays 6tocilizumab 5Blood Specimen Collection 5ruxolitinib 4ixazomib 4Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Data Collection × Plasma cell × Clear all
NCT02869555 2016-08-17

Institut Paoli Calmettes Multiple Myeloma Database

Institut Paoli-Calmettes

Recruiting
5,000 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡